UPDATED Aug 08, 2022
Discover Belgian Pharmaceuticals & Biotech Growth Stocks that are on the BEL20. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| HYLHyloris Pharmaceuticals | €12.70 | -13.5% | -9.3% | €340.4m | €20.25 | PS109.9x | E77.4% | n/a | ||
| MITRAMithra Pharmaceuticals | €8.09 | 7.9% | -60.0% | €409.2m | €25.23 | PS18.1x | E76.7% | 0% | ||
| ARGXargenx | €369.70 | 4.5% | 39.3% | €20.4b | €407.85 | PS142.3x | E74.5% | n/a | ||
| UCBUCB | €74.18 | 0.3% | -22.4% | €14.1b | €102.71 | PE15.9x | E20.2% | 1.8% | ||
| OXUROxurion | €0.31 | -1.9% | -85.5% | €16.1m | €1.25 | PS14.3x | E17.5% | n/a | ||
| MDXHMDxHealth | €0.79 | 15.5% | -37.3% | €123.2m | €1.20 | PS5.4x | E15.6% | n/a | ||
| CYADCelyad Oncology | €2.15 | 2.9% | -41.7% | €48.6m | €11.00 | PB1.6x | E-31.5% | n/a |